Lori Freedman Organogenesis Holdings Inc. (ORGO) insider trading activity

Lori Freedman is Chief Admin. and Legal Officer of Organogenesis Holdings Inc.. Currently has a direct ownership of 846,459 shares of ORGO, which is worth approximately $3.83 Million. The most recent transaction as insider was on Jun 06, 2025, when has been sold 9,022 shares (Class A Common Stock) at a price of $2.99 per share, resulting in proceeds of $26,975. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 846K

0% 3M change

80.38% 12M change

Total Value Held $3.83 Million

Lori Freedman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 06 2025	BUY Open market or private purchase	$26,975 $2.99 p/Share	9,022 Added 1.05%	846,459 Class A Common Stock
Jun 05 2025	BUY Open market or private purchase	$414,322 $2.91 p/Share	142,379 Added 14.53%	837,437 Class A Common Stock
Jun 04 2025	BUY Open market or private purchase	$284,433 $2.82 p/Share	100,863 Added 12.67%	695,058 Class A Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	162,047 Added 21.43%	594,195 Class A Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$2,390 $3.7 p/Share	646 Reduced 0.15%	432,148 Class A Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$134,968 $3.7 p/Share	36,478 Reduced 7.77%	432,794 Class A Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$5,527 $2.8 p/Share	1,974 Reduced 0.42%	469,272 Class A Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	153,061 Added 24.52%	471,246 Class A Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$2,248 $3.48 p/Share	646 Reduced 0.2%	318,185 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$92,585 $3.68 p/Share	25,159 Reduced 7.31%	318,831 Class A Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$4,982 $2.13 p/Share	2,339 Reduced 0.68%	343,990 Class A Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	278,884 Added 44.61%	346,329 Class A Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$2,103 $2.75 p/Share	765 Reduced 1.12%	67,445 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$10,614 $2.92 p/Share	3,635 Reduced 5.06%	68,210 Class A Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$23,544 $7.89 p/Share	2,984 Reduced 3.99%	71,845 Class A Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$5,952 $7.78 p/Share	765 Reduced 1.01%	74,829 Class A Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	41,843 Added 35.63%	75,594 Class A Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$39,164 $19.83 p/Share	1,975 Reduced 5.53%	33,751 Class A Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	8,808 Added 19.78%	35,726 Class A Common Stock

Lori Freedman

Chief Admin. and Legal Officer

Canton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Value

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO

Account